CARY, N.C., Dec. 16, 2025 /PRNewswire/ -- InstantGMP™, a provider of cloud-based GMP and FDA compliance software for pharmaceutical and other regulated manufacturers, announced it has aligned its ...
CES attendees saw health-tracking gadgets making bold promises: toothbrushes detecting diabetes, mirrors assessing 20-year ...
BioPharma Consulting Group today announced the launch of a new digital transformation advisory framework designed to ...
Radiopharmaceutical therapy (RPT) offers molecular-targeted treatment strategies and presents an ideal model for advancing ...
The FDA has cleared a mobile application that will connect with a next-generation multiple daily injection automated insulin ...
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including ...
The Federal Drug Administration’s current cybersecurity requirements are not appropriate for addressing and avoiding medical ...
The pharmaceutical industry is calling on the FDA to modernise how it tracks the long-term safety and efficacy of cell and ...
On Monday, the U.S. Food and Drug Administration (FDA) approved Abbott Laboratories’ (NYSE: ABT) Volt PFA System to treat patients battling atrial fibrillation (AFib). AFib is the most common type of ...
Johnson & Johnson has secured an expanded indication from FDA for its TRUFILL n‑BCA Liquid Embolic System for embolization of the middle meningeal artery for the treatment of symptomatic subacute and ...
IRVINE, Calif., December 23, 2025--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system is the first transcatheter therapy utilizing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback